Dr. Ruberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
732 Harrison Ave
Preston 3RD floor
Boston, MA 02118Phone+1 617-638-7490Fax+1 617-414-8742
Summary
- Dr. Frederick Ruberg is a cardiologist in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Medical Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 14 years. He specializes in echocardiography, cardiothoracic imaging, and non-invasive cardiology and is experienced in general cardiology, echocardiography, cardiac ct / mri, and cardiac-gated imaging techniques.
Education & Training
- Boston University Medical CenterFellowship, Cardiovascular Disease, 2001 - 2004
- Brigham and Women's HospitalResidency, Internal Medicine, 1998 - 2001
- Perelman School of Medicine at the University of PennsylvaniaClass of 1998
Certifications & Licensure
- MA State Medical License 2000 - 2025
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations Start of enrollment: 2019 May 15
- Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis Start of enrollment: 2023 Sep 19
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 2 citationsFunctional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and Outcomes.Olivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, Giada Bianchi, Jocelyn Canseco Neri
JACC. Heart Failure. 2024-12-01 - Differential Association of Transthyretin Stability with Variant and Wild-Type Transthyretin Amyloid Cardiomyopathy: The SCAN-MP Study.Manuel Urina-Jassir, Sergio Teruya, William S Blaner, Pierre-Jacques Brun, Tatiana Prokaeva
JACC. Heart Failure. 2024-12-01 - The Impact of Active Ascertainment on Sex-Specific Differences in the Prevalence and Phenotype of Transthyretin Cardiac Amyloidosis: The Screening for Cardiac Amyloido...Nicholas Chan, Andrew J Einstein, Sergio Teruya, Carlos Rodriguez, Stephen Helmke
The American Journal of Cardiology. 2024-11-23
Journal Articles
- Early Diagnosis of Cardiac Amyloidosis by Carpal Tunnel SurgeryFrederick L Ruberg, Mathew S Maurer, ScienceDirect
- Development and Validation of a Survival Staging System Incorporating BNP in Patients with Light Chain (AL) AmyloidosisFrederick L Ruberg, Vaishali Sanchorawala, Blood
Authored Content
- ACC CardiaCast: Understanding AL and ATTR Cardiac AmyloidosisMarch 2021
- Original Research Native T1 and Extracellular Volume in Transthyretin AmyloidosisMarch 2018
- More Than Meets the Eye: Time for a New Imaging Paradigm to Test for Cardiac AmyloidosisJanuary 2018
Press Mentions
- 6 Signs of Heart Problems Even Young People Should KnowMay 8th, 2024
- Providing Critical Support to Early-Stage Science: The CTSI Pilot Grant ProgramJune 9th, 2021
- National Study Seeks Earlier Diagnosis of ATTR Cardiac Amyloidosis in MinoritiesSeptember 3rd, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: